A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...
Unless officials take action to develop new medications, drug-resistant infections could kill nearly 2 million people a year ...